Welcome to Healthcare Supply Solutions Ltd Specialists in prostate cancer Innovation!
Welcome to Healthcare Supply Solutions Ltd Specialists in prostate cancer Innovation!
Signed in as:
filler@godaddy.com
The RayPilot system is designed for any linac to continuously track the prostate and outlines the urethra throughout every fraction of the radiotherapy. By knowing the exact localization of the cancerous organ, at any moment, the treatment can be more precise and significantly less of the surrounding healthy tissue will be damaged. The RayPilot system consist of three parts, the RayPilot HypoCath that is placed in the prostate and urethra to be localized and motion tracked, the RayPilot Receiving system, which is placed on any treatment couch and the RayPilot Software giving a warning when the Region of Interest moves out the predefined margins.
Want to see how raypilot protects men who are undergoing prostate radiotherapy....
Electromagnetic Tracking of Intrafraction Prostate Motion During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy for Unfavorable Prostate Tumors (pdf)
DownloadAnalysis of the intra-fractional motion of the prostate during SBRT using an EM Transmitter (pdf)
DownloadIntrafraction motion assessment in SBRT for prostate cancer- a prospective study (pdf)
DownloadReal-time intrafraction prostate motion during dose-escalated linac-based SBRT (pdf)
DownloadSBRT for localized prostate cancer- Biology meets Technology (pdf)
DownloadTreatment compliance to linac-based prostate SBRT using real time electromagnetic tracking (pdf)
DownloadTreatment outcome and compliance to dose-intensified linac-based SBRT Open Access for unfavorable prostate tumors using a novel real-time organ-motion tracking (pdf)
DownloadReconstruction of Intra-Fractional Prostate Movement and Its Effect on Dose Distribution (pdf)
DownloadTarget motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy- Results from a phase II study (pdf)
Download